Anticonvulsant Drugs and Dental Effects

On this page
  1. Direct answer
  2. What you must remember
  3. Working up the enlarged gingivae of an epileptic patient
  4. How the exam frames it
  5. Frequently asked questions
  6. Related topics

Direct answer

Phenytoin's signature in the mouth is gingival overgrowth: collagen-rich, pale, firm enlargement starting at the interdental papillae, affecting anything up to half of long-term users, dose-related, plaque-dependent and first visible within months of starting the drug. Carbamazepine contributes Stevens-Johnson syndrome risk — HLA-B*1502 carriage makes it a specifically South and East Asian pharmacogenomic danger — plus hyponatraemia and enzyme induction that sabotages co-prescribed drugs. Valproate brings thrombocytopenia and platelet dysfunction, so gingival bleeding and post-surgical ooze are its dental flags. Around all of this sits seizure-precaution dentistry: morning appointments, drugs taken as usual, a padded and calm environment, and benzodiazepines standing by.

What you must remember

  • Phenytoin overgrowth: prevalence up to about 50 per cent in long-term institutionalised cohorts, lower in community care; begins at interdental papillae within 1-6 months; plaque control reduces severity but the fibroblast phenotype drives it.
  • Mechanism: drug-affected gingival fibroblasts show increased collagen synthesis, reduced collagen phagocytosis and matrix metalloproteinase activity, with transforming growth factor beta 1 implicated — the same final pathway as ciclosporin and nifedipine overgrowth.
  • Management ladder: meticulous plaque control and chlorhexidine, professional cleaning, macrolide courses (azithromycin has trial support for reducing overgrowth), gingivectomy for aesthetic or functional cases, and neurologist negotiation for drug substitution — never stop an anticonvulsant yourself.
  • Phenytoin extras: folate-responsive megaloblastic anaemia, hirsutism, cerebellar toxicity (nystagmus, ataxxia) at high levels, gingival overgrowth as the exam's number-one association.
  • Carbamazepine: HLA-B*1502-associated SJS/TEN in South and East Asian ancestry (screening advised); hyponatraemia; leucopenia; powerful enzyme induction — warfarin, oral contraceptives and doxycycline all lose efficacy.
  • Valproate: thrombocytopenia, platelet dysfunction and thus prolonged dental bleeding — check platelet count before major surgery when history suggests bruising; also teratogenic and linked with polycystic ovarian syndrome in young women.
  • Newer agents: lamotrigine (SJS at rapid titration), topiramate (paraesthesia, xerostomia), levetiracetam (behavioural effects) — far less gingival drama.
  • Chairside seizure precautions: treat in the morning with medication taken, avoid seizure triggers (flashing, pain, stress), never place instruments near an aura-phase patient, and know that most seizures in the chair end spontaneously — protect, position laterally, time, and escalate beyond five minutes.

Working up the enlarged gingivae of an epileptic patient

A 24-year-old on phenytoin for four years presents with bulky, pale, painless gingival enlargement covering nearly a third of the crowns; his brushing is poor and his last scaling was years ago. Structure the plan in layers. Diagnosis first: the picture — firm, pink, papillary-first, anterior-worse overgrowth in a phenytoin user with visible plaque — is drug-induced gingival overgrowth until proven otherwise, but note the differential (hereditary gingival fibromatosis, leukaemic infiltration) and inspect for the signs that would shift it. Phase one is cause reduction: written plaque-control instruction, ultrasonic scaling, chlorhexidine 0.2 per cent for two weeks, and a warning that this phase decides everything — surgery on an inflamed base regrows within months. Phase two adds pharmacology: short azithromycin courses have trial evidence for shrinking phenytoin overgrowth, and many cases regress enough to avoid surgery. Phase three, if aesthetics or function still demand it, is gingivectomy or periodontal flap surgery — timed with the neurologist's knowledge, planned orthodontics considered, and the patient told plainly that overgrowth recurs if plaque does. In parallel, ask the neurologist whether substitution (lamotrigine or levetiracetam) is realistic — it is the only cure — and check the chart for folate-status anaemia and for enzyme-induction failures (contraceptives, doxycycline) if carbamazepine is ever added.

How the exam frames it

The comparison question — phenytoin versus ciclosporin versus nifedipine overgrowth — wants the shared fibroblast mechanism and the differing incidence, and the mark-winning detail is plaque dependence with onset in months. The pharmacogenomics question is carbamazepine: HLA-B*1502 carriage and SJS/TEN risk in Asian ancestry separates updated candidates. The bleeding question is valproate: thrombocytopenia plus platelet dysfunction, relevant to extraction planning. And the management long-question expects the ladder in order — plaque control, chlorhexidine, macrolide, surgery, substitution — with the explicit statement that the dentist never withdraws the antiepileptic.

Frequently asked questions

Why does phenytoin cause gingival overgrowth?

It alters gingival fibroblast function — more collagen synthesis, less collagen degradation via reduced matrix metalloproteinase activity, modulated by transforming growth factor beta 1 — on a stage of plaque inflammation.

What is the HLA-B*1502 concern with carbamazepine?

The allele, common in South and East Asian populations, strongly predisposes to carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis; genetic screening is advised before starting.

Which anticonvulsant complicates dental extraction with bleeding?

Sodium valproate — thrombocytopenia and platelet dysfunction prolong bleeding; check counts and clotting when the history suggests bruising or epistaxis.

Can drug-induced gingival overgrowth be treated without surgery?

Often yes — plaque control, professional cleaning and chlorhexidine shrink it substantially, and short macrolide courses such as azithromycin have supporting evidence; surgery is for residuals.

What chairside precautions apply to epileptic dental patients?

Morning appointments, medication taken as usual, triggers minimised, and a rehearsed seizure drill — protect the patient, turn laterally, time the seizure, and summon help if it passes about five minutes.

Practise this in the PrepElephant app

Question banks, previous-year questions, mock tests and revision tools — for Anticonvulsant Drugs and Dental Effects and BDS Pharmacology. Free to start.

Get the free app WhatsApp